SCHEMBL23212920

SCHEMBL23212920

CCOc1ccc2cc(C(=O)C(=O)OC)c(=O)oc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
RAB9A P51151 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
MAOB P27338 11/20 0.60
MAOA P21397 7/20 0.60
KDM4E B2RXH2 4/20 0.59
GAA P10253 4/20 0.59
HPGD P15428 4/20 0.59
GLA P06280 4/20 0.59
CA12 O43570 2/20 0.59
CA4 P22748 2/20 0.59
CA6 P23280 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59
CA2 P00918 1/20 0.59
CA3 P07451 1/20 0.59
HSD17B10 Q99714 2/20 0.58
TP53 P04637 1/20 0.58
MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29851566 1.00 ALDH1A1 (0.65) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL24176813 0.87 MAOB (0.76) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL24176809 0.85 ALDH1A1 (0.81) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL22059557 0.84 ALDH1A1 (0.72) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL17704676 0.84 ALDH1A1 (0.75) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL23239275 0.84 ALDH1A1 (0.64) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL24176814 0.82 ALDH1A1 (0.82) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL23212938 0.82 MAOB (0.57) ALDH1A1RAB9ASMN1; SMN2MAOBMAOA
SCHEMBL23212913 0.79 MEN1 (0.71) ALDH1A1RAB9ASMN1; SMN2MAOBKDM4E
SCHEMBL29851532 0.79 MEN1 (0.71) ALDH1A1RAB9ASMN1; SMN2MAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11981650-B2 Coumarin glyoxylates for LED photocuring IGM RESINS ITALIA S.R.L. (IT) 2024-05-14 US disclosed
US-20240067620-A1 COUMARIN GLYOXYLATES FOR LED PHOTOCURING IGM RESINS ITALIA S.R.L. (IT) 2024-02-29 US disclosed
US-20240067620-A1 COUMARIN GLYOXYLATES FOR LED PHOTOCURING IGM RESINS ITALIA S.R.L. (IT) 2024-02-29 US disclosed
US-20240067620-A1 COUMARIN GLYOXYLATES FOR LED PHOTOCURING IGM RESINS ITALIA S.R.L. (IT) 2024-02-29 US disclosed
EP-4041719-A1 COUMARIN GLYOXYLATES FOR LED PHOTOCURING IGM Resins Italia S.r.l. (IT) 2022-08-17 EP disclosed
WO-2021070152-A1 COUMARIN GLYOXYLATES FOR LED PHOTOCURING IGM RESINS ITALIA S.R.L. (IT) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067620-A1 COUMARIN GLYOXYLATES FOR LED PHOTOCURING AGXT, GRHPR, GLO1 ALDH1A1 1173/4885RAB9A 4854/4885SMN1; SMN2 4883/4885
US-11981650-B2 Coumarin glyoxylates for LED photocuring AGXT, GRHPR, GLO1 ALDH1A1 1173/4885RAB9A 4854/4885SMN1; SMN2 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.